Skip to content

MDMA: all studies

Page 174 of 346: studies 1,731 to 1,740 of 3,454, newest first. Back to the MDMA overview

Research

Preventing problems in Ecstasy users: reduce use to reduce harm.

Journal of Psychoactive Drugs 2002 Matthew J. Baggott

Increasing use of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") has been accompanied by concern about acute and possible long-term toxicity. This article discusses acute serious toxicity, chronic toxicity, and common problems associated with Ecstasy use, as well as the implications of these areas for prevention programs targeted at current Ecstasy users. The low incidence of serious...

MDMA misrepresentation: an unresolved problem for Ecstasy users.

Journal of Psychoactive Drugs 2002 Gregory N Hayner

The demand for MDMA (methylenedioxymethamphetamine) has increased, especially among teenagers 12 to 18 years old. It is estimated that approximately 2.8 million teens have at least tried this drug. Coincident with this trend has been an increasing body of literature that questions the safety of MDMA consumption in terms of possibly permanent neurological damage, associated with behavioral and...

Pneumomediastinum following Ecstasy (methylenedioxymetamphetamine, MDMA) ingestion in two people at the same 'rave'.

The Journal of Laryngology and Otology January 2002 Darius Rejali, Paul Glen, Nicholas Odom

Ecstasy is a class A controlled drug often consumed by the young population for recreational purposes. Documented complications of its use include hyperpyrexia, disseminated intravascular coagulation (DIC), renal failure and rhabdomyolysis. We report on two patients who developed pneumomediastinum after Ecstasy abuse. Both patients obtained and consumed the drug at the same establishment and...

The shaman and the rave party: social pharmacology of ecstasy.

Substance Use & Misuse 2002 Paolo Nencini 17 citations

Current psychobiological models of drug addiction are focused on the capability of drugs to cause a pathological exploitation of the neural rewarding system. This approach has emphasized the role of hedonistic factors in the etiology of drug addiction. Comparing primitive and modern settings of intoxication, such as shamanic rituals and rave parties, it is possible to confute this assumption....

Behavioral Psychopharmacology of MDMA and MDMA-Like Drugs: A Review of Human and Animal Studies

Addiction Research & Theory 2002 Diana L. Martinez-Price, Kirsten Krebs-Thomson, Mark A. Geyer 16 citations

Since being classified as a Schedule I controlled substance, MDMA (3,4-methylenedioxy-N-methylamphetamine; "ecstasy") has been the subject of controversy regarding its potential therapeutic usage, increased use by young people in the "Rave" culture, and issues of potential neurotoxicity. This review article summarizes much of the animal and human studies of the general behavioral effects of...

Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern Spain

European Addiction Research 2002 Julio Bobes, Pilar A. Sáiz, María Paz García‐portilla et al. 34 citations

<i>Aim: </i>To measure the prevalence of 3,4-methylenedioxymethamphetamine (MDMA) and other drug use in young males entering compulsory military service in Asturias (northern Spain) and to define trends in MDMA use in this group during the period from 1995 to 1999. We also sought to determine whether MDMA users have distinct personality features or higher levels of sensation seeking....

Ecstasy (MDMA) Deaths in New York City: A Case Series and Review of the Literature

Journal of Forensic Sciences 2002 James R. Gill, Jude R. Hayes, Ian S. Desouza et al. 77 citations

Abstract MDMA (“ecstasy”) has gained renewed popularity as a drug of abuse. To access the epidemiology and causes of death of MDMA-positive fatalities, all deaths investigated by the OCME that tested positive for MDMA (22 deaths) between January 1997 and June 2000 were reviewed. There were three deaths in each 1997 and 1998, eleven in 1999, and five in the first part of 2000. Of these 22...

Long-Term Neuropsychiatric Consequences of "Ecstasy" (MDMA): A Review

Harvard Review of Psychiatry 2002 Alonso Montoya, Renée Sorrentino, Scott E Lukas et al. 102 citations

The recreational drug "ecstasy" (3,4-methylenedioxymethamphetamine, or MDMA) is widely used by young people throughout the world. Experimental studies indicate that MDMA damages serotonergic neurons in animals and possibly in humans. Repeated use may induce long-term neurotoxic effects, with cognitive and behavioral implications. We reviewed both the preclinical and the clinical literature to...

The pharmacology of the acute hyperthermic response that follows administration of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats

British Journal of Pharmacology 2002 Annis O. Mechan, B. Moreno Esteban, Esther O’shea et al. 219 citations

The pharmacology of the acute hyperthermia that follows 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) administration to rats has been investigated. MDMA (12.5 mg kg −1 i.p.) produced acute hyperthermia (measured rectally). The tail skin temperature did not increase, suggesting that MDMA may impair heat dissipation. Pretreatment with the 5‐HT 1/2 antagonist methysergide (10 mg kg −1 ), the...

From the Songs of Ecstasy

Songs of Ecstasy December 13, 2001 Hugh B. Urban

Abstract A series of select translations is presented from the Bhāver Gīta, the main song text of the Kartābhajās, a Bengali sect devoted to Tantra in colonial Calcutta, Bengal. The author has chosen the songs that he considers most significant and organized them under thematic headings: Company songs, Songs of the marketplace, Songs of mystical belief and esoteric practice, Songs of lust and...